Nanal particle vaccines, which is one of the main technologies are pursuing for a kind of pan or chronovirous shots. In theory, in theory, might train the immune system to generate cross reactive anni bodies against multiple chrono virusssem. There's a few o phase one human trials, many that's what they're showing that may be happening on some of thee early experiments. But someone has to put big bucks behind it if the research continues to be promising.
Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek."
Hosted by Carol Massar and Tim Stenovec
Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 119, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.
You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW
See omnystudio.com/listener for privacy information.